Date Range
Date Range
Date Range
Pioneering New Methods of Drug Delivery. Inc provides medical device developers with cutting-edge absorbable polymer technology for implantable drug delivery. Our patented process enables fiber extrusion at room temperature with drugs and therapeutic agents previously impossible to incorporate in implant devices. In more ways than ever, device developers can now take advantage of drug delivery through our ELUTE. TissueGen Expands Core Team and .
is a clinical-stage bio-pharmaceutical company focused on developing novel regenerative therapies in the field of cell therapy. Our proprietary technology allows for the optimized delivery of therapeutic proteins to repair and rebuild damaged cartilage, bone, disc, and nerve tissue for the treatment of various orthopedic diseases and degenerative disorders. Site Designed by HindSite Interactive.
Forgot Password or Username? Will draw for points! Deviant for 4 Years.
Cancer Driver STAT3 reduces metastasis in prostate cancer. Beatrice Grabner presents STAT3 playing an important role in the defence against tumors in Nature Communications. Lung cancer is one of the most common tumor-related causes of death, because it is one of the most aggressive cancers. Since the treatment methods especially in cigarette smoke-induced lung cancer are extremely limited, there is an urgent medical need to establish new treatment options .